Table 3.
Risk Factor | CVT, n = 25 | JVT, n = 16 | UEDVT, n = 33 | AVT, n = 33 | P |
---|---|---|---|---|---|
Cancer, n (%) | 6 (24.0%) | 9 (56.2%) | 7 (21.2%) | 25 (75.7%) | <.01 |
Solid cancer, n (%) | 3 (12.0%) | 8 (50.0%) | 6 (18.2%) | 19 (57.6%) | |
Hematological cancer, n (%) | 3 (12.0%) | 1 (6.2%) | 1 (3.0%) | 6 (18.1%) | |
−JAK2+ MPN, n (%) | 3 (12.0%) | 0 (0.0%) | 0 (0.0%) | 4 (12.1%) | |
Oral contraceptives, n/number of women (%) | 5/18 (27.7%) | 0/8, (0.0%) | 0/17, (0.0%) | 0/11, (0.0%) | |
CVC, n (%) | 0 (0.0%) | 0 (0.0%) | 16 (48.4%) | 0 (0.0%) | |
PM, n (%) | 0 (0.0%) | 0 (0.0%) | 2 (1.8%) | 0 (0.0%) | |
Thoracic outlet syndrome, n (%) | 0 (0.0%) | 0 (0.0%) | 6 (18.1%) | 0 (0.0%) | |
Liver cirrhosis, n (%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 5 (15.1%) | |
Trauma, n (%) | 0 (0.0%) | 1 (6.2%) | 0 (0.0%) | 0 (0.0%) | |
Sepsis, n (%) | 0 (0.0%) | 1 (6.2%) | 0 (0.0%) | 0 (0.0%) | |
DIC, n (%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (3.0%) | |
Pancreatitis, n (%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (3.0%) | |
Surgery, n (%) | 1 (4.0%) | 0 (0.0%) | 0 (0.0%) | 1 (3.0%) | |
None of the above-listed risk factors | 13 (52.0%) | 5 (31.2%) | 2 (6.1%) | 0 (0.0%) | <.0001 |
Abbreviations: AVT, abdominal vein thrombosis; CVC, central venous catheter; CVT, cerebral vein thrombosis; DIC, disseminated intravascular coagulation; JVT, jugular vein thrombosis; MPN, myeloproliferative neoplasm; PM, pacemaker; UEDVT, upper extremities deep vein thrombosis.